Poitiers University Hospital
chu-poitiers.frLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
310
Active
63
Phase 3
19
Total enrollment
177,708
Pipeline matrix
Showing 21 of 21 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Prevenar 13 + Pneumovax 23 | — | — | — | — | — | 1 | |
| PREVENAR20 | — | — | — | — | — | 1 | |
| Blood samples for PK | — | — | — | — | — | 1 | |
| lenalidomide | — | — | — | — | 2 | ||
| Isatuximab | — | — | — | — | 2 | ||
| Dexamethasone | — | — | — | — | 2 | ||
| treatment of TKI in CML | — | — | — | — | — | 1 | |
| Bortezomib | — | — | — | — | — | 1 | |
| inhaled Ambisome® | — | — | — | — | — | 1 | |
| inhaled placebo | — | — | — | — | — | 1 | |
| Itraconazole | — | — | — | — | — | 1 | |
| blood plasma sample | — | — | — | — | — | 1 | |
| blood sampling | — | — | — | — | — | 1 | |
| Nicotine replacement | — | — | — | — | — | 2 | |
| Antiarrhythmic drug | — | — | — | — | — | 1 | |
| Blood, urinary and feces collection | — | — | — | — | — | 1 | |
| Imatinib | — | — | — | — | — | 1 | |
| Renal clairance study | — | — | — | — | — | 1 | |
| Usual Practices | — | — | — | — | — | 1 | |
| Nicotine Replacement Therapy | — | — | — | — | — | 1 | |
| Bevacizumab | — | — | — | — | — | 1 |
Next readouts
- 2024-06-18
- 2025-05
- 2026-06
- 2026-08-01
- 2026-09
- 2026-11-13
- 2027-01
- 2027-06
- 2028-01
- 2028-02-03
Top conditions
- Chronic Myeloid Leukemia8
- Acute Respiratory Failure7
- Failed Back Surgery Syndrome5
- Pain4
- Breast Cancer4
- Alzheimer Disease4
- Sleep Quality4
- Healthy Volunteers3
Frequently asked questions about Poitiers University Hospital
- How many clinical trials does Poitiers University Hospital have on ClinicalTrials.gov?
- Poitiers University Hospital is listed as the lead sponsor on 310 clinical trials in ClinicalTrials.gov, 63 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Poitiers University Hospital's trials are in Phase 3?
- 19 of Poitiers University Hospital's trials are in Phase 3, spread across 21 active drug programs.
- What therapeutic areas does Poitiers University Hospital focus on?
- Poitiers University Hospital's most-studied conditions on ClinicalTrials.gov are Chronic Myeloid Leukemia, Acute Respiratory Failure, Failed Back Surgery Syndrome, Pain, Breast Cancer.
- When are Poitiers University Hospital's next clinical trial readouts?
- Poitiers University Hospital has 10 upcoming primary-completion readouts tracked here; the soonest is “Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone With/Without Bortezomib in the Treatment of Newly Diagnosed Non Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years).”, expected around 2024-06-18.